Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users
Darshan Singh, Nelson Jeng‐Yeou Chear, Suresh Narayanan, et al.
Journal of Ethnopharmacology (2019) Vol. 249, pp. 112462-112462
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Past-Year Kratom Use in the U.S.: Estimates From a Nationally Representative Sample
Joseph J. Palamar
American Journal of Preventive Medicine (2021) Vol. 61, Iss. 2, pp. 240-245
Open Access | Times Cited: 62
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence
Lisa Wilson, Hannah M. Harris, Shainnel O. Eans, et al.
Drug and Alcohol Dependence (2020) Vol. 216, pp. 108310-108310
Closed Access | Times Cited: 52
Activity of Mitragyna speciosa (“Kratom”) Alkaloids at Serotonin Receptors
Francisco León, Samuel Obeng, Marco Mottinelli, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13510-13523
Open Access | Times Cited: 51
Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal
Lisa Wilson, Soumen Chakraborty, Shainnel O. Eans, et al.
Cellular and Molecular Neurobiology (2021) Vol. 41, Iss. 5, pp. 1131-1143
Open Access | Times Cited: 48
Accelerated Solvent Extractions (ASE) of Mitragyna speciosa Korth. (Kratom) Leaves: Evaluation of Its Cytotoxicity and Antinociceptive Activity
Yong Sean Goh, Thiruventhan Karunakaran, Vikneswaran Murugaiyah, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3704-3704
Open Access | Times Cited: 43
Kratom use as more than a “self-treatment”
Kirsten E. Smith, Kelly E. Dunn, Jeffrey M. Rogers, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 6, pp. 684-694
Closed Access | Times Cited: 37
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a cross-sectional investigation
Oliver Grundmann, Charles A. Veltri, Diana Morcos, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 4, pp. 433-444
Closed Access | Times Cited: 31
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys
Jeffrey M. Rogers, Kayla Colvin, David H. Epstein, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats
Shyam H. Kamble, Erin C. Berthold, Tamara I. King, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 4, pp. 1104-1112
Open Access | Times Cited: 36
Kratom Abuse Potential 2021: An Updated Eight Factor Analysis
Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26
The Potential for Kratom as an Antidepressant and Antipsychotic.
Lindsay E Johnson, Lilian Balyan, Amy Magdalany, et al.
(2020) Vol. 93, Iss. 2, pp. 283-289
Closed Access | Times Cited: 37
Kratom instrumentalization for severe pain self-treatment resulting in addiction – A case report of acute and chronic subjective effects
Elisabeth Müller, Thomas Hillemacher, Christian P. Müller
Heliyon (2020) Vol. 6, Iss. 7, pp. e04507-e04507
Open Access | Times Cited: 33
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32
The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 2, pp. 223-228
Closed Access | Times Cited: 27
Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits
Oliver Grundmann, Robert G. Hendrickson, Michael I. Greenberg
Disease-a-Month (2022) Vol. 69, Iss. 6, pp. 101442-101442
Closed Access | Times Cited: 20
Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products
Preston K. Manwill, Laura Flores‐Bocanegra, Manead Khin, et al.
Planta Medica (2022) Vol. 88, Iss. 09/10, pp. 838-857
Open Access | Times Cited: 19
Natural products as the therapeutic strategies for addiction
Rui Yu, Delei Kong, Cai Liao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116687-116687
Open Access | Times Cited: 4
Kratom ( Mitragyna speciosa Korth.) Use Among Poly-Drug Users in Southeast Asia: A Systematic Review
Neshalatha Govarthnapany, Roman Gabrhelík, Darshan Singh
Journal of Psychoactive Drugs (2025), pp. 1-11
Closed Access
Assessing the therapeutic potential and toxicity of Mitragyna speciosa in opioid use disorder
Abhisheak Sharma, Christopher R. McCurdy
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 17, Iss. 3, pp. 255-257
Open Access | Times Cited: 29
Pharmacokinetics and Safety of Mitragynine in Beagle Dogs
Elizabeth A. Maxwell, Tamara I. King, Shyam H. Kamble, et al.
Planta Medica (2020) Vol. 86, Iss. 17, pp. 1278-1285
Open Access | Times Cited: 28
Herbal and dietary supplement induced liver injury: Highlights from the recent literature
Stephanie Woo, William D. Davis, Soorya Aggarwal, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 9, pp. 1019-1041
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top